Merck’s Strong Q2 Overshadowed By Gardasil Sales Decline In China

Revenue Guidance Raised, EPS Expectation Lowered

Merck sign atop Merck Research Laboratories campus in South San Francisco
Merck expects up to $64.4bn in full-year 2024 sales • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip